The stock of Sanofi ADR (SNY) has gone up by 0.18% for the week, with a 5.45% rise in the past month and a 6.82% rise in the past quarter. The volatility ratio for the week is 1.76%, and the volatility levels for the past 30 days are 1.75% for SNY. The simple moving average for the past 20 days is 4.95% for SNY’s stock, with a 0.57% simple moving average for the past 200 days.
Is It Worth Investing in Sanofi ADR (NASDAQ: SNY) Right Now?
Sanofi ADR (NASDAQ: SNY) has a higher price-to-earnings ratio of 21.58x compared to its average ratio, The 36-month beta value for SNY is at 0.59. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for SNY is 2.51B, and currently, shorts hold a 0.13% of that float. The average trading volume for SNY on May 08, 2024 was 2.06M shares.
SNY) stock’s latest price update
Sanofi ADR (NASDAQ: SNY)’s stock price has gone rise by 1.11 in comparison to its previous close of 49.57, however, the company has experienced a 0.18% increase in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-25 that Sanofi (SNY) posts first-quarter 2024 results and maintains the earnings growth guidance for the year.
Analysts’ Opinion of SNY
Many brokerage firms have already submitted their reports for SNY stocks, with Morgan Stanley repeating the rating for SNY by listing it as a “Equal-Weight.” The predicted price for SNY in the upcoming period, according to Morgan Stanley is $55 based on the research report published on January 23, 2024 of the current year 2024.
SNY Trading at 4.55% from the 50-Day Moving Average
After a stumble in the market that brought SNY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.05% of loss for the given period.
Volatility was left at 1.75%, however, over the last 30 days, the volatility rate increased by 1.76%, as shares surge +6.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.68% upper at present.
During the last 5 trading sessions, SNY fell by -0.09%, which changed the moving average for the period of 200-days by -7.30% in comparison to the 20-day moving average, which settled at $47.90. In addition, Sanofi ADR saw 0.78% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SNY
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.66 for the gross margin
The net margin for Sanofi ADR stands at 0.12. Equity return is now at value 7.22, with 4.25 for asset returns.
Currently, EBITDA for the company is 12.96 billion with net debt to EBITDA at 0.55. When we switch over and look at the enterprise to sales, we see a ratio of 2.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
In conclusion, Sanofi ADR (SNY) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
